Annual SGA
$411.36 M
+$88.24 M+27.31%
December 31, 2024
Summary
- As of February 23, 2025, AXSM annual SGA is $411.36 million, with the most recent change of +$88.24 million (+27.31%) on December 31, 2024.
- During the last 3 years, AXSM annual SGA has risen by +$344.71 million (+517.23%).
- AXSM annual SGA is now at all-time high.
Performance
AXSM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
N/A
December 31, 2024
Summary
- AXSM quarterly SGA is not available.
Performance
AXSM Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
N/A
December 31, 2024
Summary
- AXSM TTM SGA is not available.
Performance
AXSM TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AXSM Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.3% | - | - |
| 3 y3 years | +517.2% | - | - |
| 5 y5 years | +2925.1% | - | - |
AXSM Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +517.2% | ||||
| 5 y | 5-year | at high | +2925.1% | ||||
| alltime | all time | at high | >+9999.0% |
Axsome Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $411.36 M(+27.3%) | - | - |
| Sep 2024 | - | $95.56 M(-7.7%) | $384.90 M(+3.3%) |
| Jun 2024 | - | $103.55 M(+4.6%) | $372.52 M(+7.1%) |
| Mar 2024 | - | $98.97 M(+14.0%) | $347.90 M(+7.7%) |
| Dec 2023 | $323.12 M(+102.9%) | $86.81 M(+4.4%) | $323.12 M(+8.5%) |
| Sep 2023 | - | $83.19 M(+5.4%) | $297.81 M(+16.6%) |
| Jun 2023 | - | $78.94 M(+6.4%) | $255.52 M(+23.0%) |
| Mar 2023 | - | $74.19 M(+20.6%) | $207.74 M(+30.4%) |
| Dec 2022 | $159.25 M(+139.0%) | $61.50 M(+50.4%) | $159.25 M(+36.6%) |
| Sep 2022 | - | $40.89 M(+31.2%) | $116.58 M(+21.5%) |
| Jun 2022 | - | $31.16 M(+21.2%) | $95.92 M(+18.3%) |
| Mar 2022 | - | $25.70 M(+36.5%) | $81.10 M(+21.7%) |
| Dec 2021 | $66.65 M(+130.6%) | $18.83 M(-6.9%) | $66.65 M(+14.6%) |
| Sep 2021 | - | $20.23 M(+23.8%) | $58.18 M(+31.4%) |
| Jun 2021 | - | $16.34 M(+45.3%) | $44.28 M(+25.9%) |
| Mar 2021 | - | $11.25 M(+8.6%) | $35.18 M(+21.7%) |
| Dec 2020 | $28.90 M(+112.5%) | $10.36 M(+63.6%) | $28.90 M(+21.6%) |
| Sep 2020 | - | $6.33 M(-12.5%) | $23.76 M(+15.7%) |
| Jun 2020 | - | $7.24 M(+45.6%) | $20.54 M(+30.4%) |
| Mar 2020 | - | $4.97 M(-4.8%) | $15.75 M(+15.8%) |
| Dec 2019 | $13.60 M | $5.22 M(+67.8%) | $13.60 M(+27.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $3.11 M(+27.3%) | $10.67 M(+9.3%) |
| Jun 2019 | - | $2.45 M(-13.2%) | $9.77 M(+0.1%) |
| Mar 2019 | - | $2.82 M(+22.6%) | $9.76 M(+4.4%) |
| Dec 2018 | $9.35 M(+29.8%) | $2.30 M(+4.4%) | $9.35 M(+3.9%) |
| Sep 2018 | - | $2.20 M(-9.7%) | $9.00 M(+4.4%) |
| Jun 2018 | - | $2.44 M(+1.2%) | $8.63 M(+8.8%) |
| Mar 2018 | - | $2.41 M(+23.6%) | $7.93 M(+10.0%) |
| Dec 2017 | $7.21 M(+13.6%) | $1.95 M(+6.8%) | $7.21 M(+1.9%) |
| Sep 2017 | - | $1.83 M(+4.8%) | $7.08 M(+2.7%) |
| Jun 2017 | - | $1.74 M(+3.4%) | $6.89 M(+3.2%) |
| Mar 2017 | - | $1.69 M(-7.3%) | $6.67 M(+5.2%) |
| Dec 2016 | $6.34 M(+162.2%) | $1.82 M(+11.0%) | $6.34 M(+15.9%) |
| Sep 2016 | - | $1.64 M(+7.2%) | $5.47 M(+26.3%) |
| Jun 2016 | - | $1.53 M(+12.7%) | $4.33 M(+32.9%) |
| Mar 2016 | - | $1.36 M(+43.3%) | $3.26 M(+34.7%) |
| Dec 2015 | $2.42 M(+73.7%) | $946.60 K(+89.5%) | $2.42 M(+16.7%) |
| Sep 2015 | - | $499.40 K(+9.4%) | $2.07 M(+5.3%) |
| Jun 2015 | - | $456.40 K(-11.7%) | $1.97 M(+30.2%) |
| Mar 2015 | - | $516.80 K(-14.0%) | $1.51 M(+51.9%) |
| Dec 2014 | $1.39 M(+357.9%) | $600.80 K(+52.0%) | $996.00 K(+152.0%) |
| Sep 2014 | - | $395.20 K | $395.20 K |
| Dec 2013 | $304.20 K | - | - |
FAQ
- What is Axsome Therapeutics annual SGA?
- What is the all time high annual SGA for Axsome Therapeutics?
- What is Axsome Therapeutics annual SGA year-on-year change?
- What is the all time high quarterly SGA for Axsome Therapeutics?
- What is the all time high TTM SGA for Axsome Therapeutics?
What is Axsome Therapeutics annual SGA?
The current annual SGA of AXSM is $411.36 M
What is the all time high annual SGA for Axsome Therapeutics?
Axsome Therapeutics all-time high annual SGA is $411.36 M
What is Axsome Therapeutics annual SGA year-on-year change?
Over the past year, AXSM annual SGA has changed by +$88.24 M (+27.31%)
What is the all time high quarterly SGA for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly SGA is $103.55 M
What is the all time high TTM SGA for Axsome Therapeutics?
Axsome Therapeutics all-time high TTM SGA is -$8.23 M